Back to search

Ireland· IE-PA-EU/1/14/984/001-005

Xadago 50 mg Film-coated tablet

A dopaminergic agents product containing safinamide methanesulfonate, registered in Ireland by Zambon S.p.A..

ATC N04B

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedXadago 50 mg Film-coated tabletATCN04BREGISTER NO.IE-PA-EU/1/14/984/001…PACKS LISTED1CHECKEDSeptember 28, 2026

The record

At a glance

HPRA (Ireland)
Active substance
Safinamide methanesulfonate
Manufacturer
Zambon S.p.A.
Country
Ireland (IE)
ATC code
N04B
ATC class
DOPAMINERGIC AGENTS
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/14/984/001-005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Safinamide methanesulfonate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All safinamide methanesulfonate products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Belgium · Safinamide Ab, Safinamide Eg
  • Cyprus · Orvago
  • Germany · Safinamid Al, Safinamid Puren
  • Denmark · Safinamid Vivanta
  • Estonia · Safinamide Teva
  • Spain · Safinamida Aurovitas, Safinamida Cinfa
  • Finland · Safinamide Vivanta
  • United Kingdom (Northern Ireland) · Safinamide Amarox, Safinamide Milpharm
  • Greece · Orvago, Safinamide Win Medica
  • Croatia · Safinamid Msn, Safinamide Msn
  • Iceland · Xadago
  • Italy · Safinamide Aurobindo, Safinamide Doc
  • Liechtenstein · Xadago
  • Lithuania · Safinamide Teva
  • Luxembourg · Safinamide Eg
  • Latvia · Safinamide Teva
  • Malta · Safinamide Nio
  • Netherlands · Safinamide Vivanta
  • Norway · Safinamide Vivanta, Xadago
  • Portugal · Safinamida Aurobindo, Safinamida Generis
  • Sweden · Orvago, Safinamid Doc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/564508bd-a82f-4b4f-b23a-3752c6f807c0
GET /v1/drugs/564508bd-a82f-4b4f-b23a-3752c6f807c0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N04B"
  ],
  "strength": null,
  "pa_number": "EU/1/14/984/001-005",
  "substances": [
    "Safinamide methanesulfonate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "24/02/2015",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about safinamide methanesulfonate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.